TS-063069 — In the wake of the global pandemic caused by SARS-CoV-2, the need for rapid, accurate, and efficient diagnostic methods for respiratory viral infections has become more critical than ever. Traditional diagnostic methods, while reliable, are often time-consuming, labor-intensive, and lack the neces…

TS-062690 — Novel niclosamide analogues with improved bioavailability and mitigated dose-limiting toxicities.

TS-062553 — The Need The swift and accurate diagnosis of COVID-19 and other viruses is crucial in preventing their spread. Current detection methods like PCR and antibody testing have limitations, including long run times, sample preparation, and high false negative rates. Moreover, with the rapid mutation and…

TS-062232 — The Need The current demand in the market is for a safe and effective SARS-CoV-2 vaccine that can induce both antibody and T cell responses. The traditional understanding of antibody-based immunity is incomplete, as virus-infected cells are eliminated with the help of T cells. To combat SARS-CoV-2 …

TS-062231 — The Need: Addressing the Urgent Need for a Safe and Effective SARS-CoV-2 Vaccine for Infants and Children The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has brought about significant economic, emotional, and public health challenges worldwide. The pressing dema…

TS-062224 — The Need: Advancing Nonwoven Fibrous Webs for Personal Protective Equipment The demand for high-performance personal protective equipment (PPE) has been escalating rapidly, necessitating improved nonwoven materials that can meet stringent safety requirements. Traditional nonwoven fibrous webs lack …

TS-050296 — A sequencing-based diagnostic assay for SARS-CoV-2 with sensors of immune activation and the viral microbiota.